Navigation Links
Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009
Date:7/14/2009

ate to the effect that the Interim Report gives a true and fair view of the Company's assets and liabilities, financial position, results of operations and cash flows. Furthermore, we consider the Interim Report to give a true and fair statement of the developments in the Group's activities and financial affairs, results of operations and the Company's financial position as a whole as well as a description of the significant risks and uncertainties the Company faces.


    Board of Executives


        Soren Tulstrup      Henrik Stage

        President & CEO     Vice President & CFO


    Board of Directors


        Flemming         Walter         Claus          Soren Carlsen
        Ornskov          Wenninger      Braestrup

        Chairman         Vice Chairman  Director       Director



        Edwin de Graaf   Anders Hinsby  Martien van    Holger
                                        Osch           Reithinger

        Director         Director       Director       Director

Santaris Pharma forward looking statements

This written announcement contains forward-looking statements, identified by the use of words such as "believes," "expects," "may," "will," "should", "potential," "anticipates," "plans" or "intends" and similar expressions. Such forward-looking statements involve risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from the future results, events or developments indicated in this announcement. Such factors include, but are not limited to the timing, success and cost of clinical studies; the ability to obtain regulatory approval of products, market acceptance of and future demand for Santaris Pharma products and the impact of competitive products and pricing. These factors should be considered carefully and readers are cautioned not to place undue reliance on such forward-looking statemen
'/>"/>

SOURCE Santaris Pharma
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Santaris Pharma to Present at 10th Annual Biotechnology Industry Organisation CEO & Investor Conference - February 11th, 2008
2. Santaris Pharma Delivers Six LNA-Based RNA Inhibitors to Enzon Pharmaceuticals Ahead of Schedule
3. Santaris Pharma Director Appointed Adjunct Professor in RNA Biology at the University of Aalborg, Denmark
4. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
5. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
6. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
7. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
8. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
9. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Mass. , June 2, 2015 /PRNewswire/ ... a biotechnology company focused on discovering and ... of dermatology and ophthalmology, today announced that Dr. ... Officer, will present at the 23 rd ... six-day world congress will include in-depth presentations ...
(Date:6/2/2015)...  Alere Inc. (NYSE: ALR ), a ... House Antibiotic Stewardship Forum today to announce a ... the President,s National Action Plan to Combat Antibiotic-Resistant ... measurable goals and objectives over the next five ... protect their patients through antibiotic stewardship, slow the ...
(Date:6/2/2015)... Junction, AZ (PRWEB) June 02, 2015 ... light microscope technology, Yancy Corporation is enabling ... any desired material and biological sample, displaying the full ... electron bonds between atoms. , Jeff Porter, Co-Founder of ... physics are just that – rare. They come once ...
(Date:6/2/2015)... Sunnyvale, CA (PRWEB) June 02, 2015 ... their official United States distributor for the Moenninghoff ... Finger stated, “I am pleased to announce that the ... U.S. market. For our firm, founded in 1916, this ... that R.M. Hoffman is the kind of professional distributor ...
Breaking Biology Technology:RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 2RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 3RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 4Alere Announces Broad Initiatives to Help Combat Antibiotic Resistance during White House Antibiotic Stewardship Forum 2Scientists Eying Rare Discovery Of New Physics & Light Microscope Technology 2R.M. Hoffman Company designated official United States distributor for the Moenninghoff product line. 2R.M. Hoffman Company designated official United States distributor for the Moenninghoff product line. 3
... S-HERTOGENBOSCH, The Netherlands , April 27, 2010 ... with the most recent insights in oncology to develop novel,therapeutics, secures seed ... , , ... April 27, 2010 - Immunovo BV, a new,biotechnology company developing a ...
... ... the life sciences research, discovery, and clinical trials process. , ... Needham, MA (PRWEB) April 27, 2010 -- CHI,s Bio-IT World ... ceremony held on Wednesday, April 21st at the World Trade Center Boston during the Bio-IT ...
... 27 Two months after launching a strategic review of its character ... an agreement to sell United Media Licensing for $175 million to ... , , ... of the late Charles Schulz , who created the beloved Peanuts characters, ...
Cached Biology Technology:Immunovo BV- A New Biotechnology Company is Announced 2Best of Show Award Winners Named at Bio-IT World Conference & Expo 2Best of Show Award Winners Named at Bio-IT World Conference & Expo 3Best of Show Award Winners Named at Bio-IT World Conference & Expo 4Scripps Announces Sale of United Media's Licensing Business for $175 Million 2Scripps Announces Sale of United Media's Licensing Business for $175 Million 3
(Date:5/27/2015)... 27, 2015   Codonics (codonics.com), ... and image documentation solutions and Omnicell ... automation solutions, is pleased to announce their ... Safe Label System® (SLS), an award-winning FDA ... the Omnicell Anesthesia Workstation, helps prevent medication ...
(Date:5/22/2015)... OXFORD, CT , May 22, 2015  NXT-ID, Inc. ... from June 1st, it will be ending its promotional pricing ... www.wocketwallet.com . Laurence Savin , Head of ... our exclusive promotional pricing until the end of May. To ... at wocketwallet.com/invite and when we open the store on June ...
(Date:5/21/2015)... , May 21, 2015 The Sync ... of music for health, today announced a collaborative partnership ... The partnership will center on collaboration on original research, ... first step in the collaboration, The Sync Project and ... "Music as Medicine" in the 2015-2016 academic year.  ...
Breaking Biology News(10 mins):Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3
... researchers came up with the powerful,cocktail of anti-HIV drugs ... had found a way to finally rid the,body of ... goes into,hiding, dormant and practically undetectable in the body ... virus at bay,it’s still quite capable ?given the right ...
... DNA (mtDNA) play,an important role in the development ... Emory University School of Medicine and the,University of ... in the Proceedings of the National Academy of ... DNA, is found,in the hundreds of mitochondria located ...
... Optobionics Corporation involving the implantation of a retina ... Atlanta Veterans Affairs Rehabilitation Research & Development Center ... patients all have retinitis pigmentosa with moderate-to-severe vision ... been chosen to conduct the expanded trial. Other ...
Cached Biology News:Jefferson Virologists Coax HIV Out of Hiding 2Mitochondrial DNA mutations play significant role in prostate cancer 2Emory Eye Center Implants Its First Retinal Chips In Patients With Retinitis Pigmentosa 2
...
...
Formulation: Phosphate-buffered saline, pH 7.2, containing 0.09% sodium azide....
... and analysis software for electrophysiology ... Contains powerful stimulus generation capabilities ... including automated waveform feature detection ... many electrophysiology specific functions including ...
Biology Products: